New antiepileptic drugs, cost-efficacy analysis
Objective: to optimize pharmacotherapy in patients with epilepsy and to evaluate the clinical and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine, topiramate, and oxcarbazepine.Patients and methods. The study enrolled 134 patients (women, 69.03%;...
| Glavni autori: | , , |
|---|---|
| Format: | Članak |
| Jezik: | Russian |
| Izdano: |
IMA-PRESS LLC
2014-01-01
|
| Serija: | Неврология, нейропсихиатрия, психосоматика |
| Teme: | |
| Online pristup: | https://nnp.ima-press.net/nnp/article/view/226 |